- Home
- PAAI vs MIST Comparison
PAAI vs MIST Comparison
Compare PAAI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAAI | MIST |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8M | 95.3M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PAAI | MIST |
|---|---|---|
| Price | $0.73 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $5.86 |
| AVG Volume (30 Days) | 678.9K | ★ 1.0M |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 191.93 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $16,892,000.00 | N/A |
| Revenue This Year | N/A | $147.62 |
| Revenue Next Year | $5.00 | $476.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.46 | N/A |
| 52 Week Low | $0.80 | $0.70 |
| 52 Week High | $3.47 | $3.06 |
Technical Indicators
Market Signals| Indicator | PAAI | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 35.20 |
| Support Level | N/A | N/A |
| Resistance Level | $1.90 | $1.42 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 2.49 | 9.00 |
Price Performance
Historical ComparisonAbout PAAI Paradium.AI Inc. Common Stock
Paradium.AI Inc is an AI technology company. The group operates as a centralized, AI-optimized infrastructure that puts the tools, data, and reach media entrepreneurs could never build alone directly into their hands. Its products are Infosentience, Encore, and Cutter Studios.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.